New data reveals that retatrutide, a innovative medication, might represent a major improvement in body loss . This drug combines the actions of a GLP-1 agonist and a GIP analog, seemingly offering a more impact than current therapies . Clinical trials have revealed positive results , including substantial declines in weight and improvements in re